Please login to the form below

Not currently logged in
Email:
Password:

Alfred Sandrock

This page shows the latest Alfred Sandrock news and features for those working in and with pharma, biotech and healthcare.

Biogen and Eisai present new data for controversial Alzheimer's drug Aduhelm at AAIC

Biogen and Eisai present new data for controversial Alzheimer's drug Aduhelm at AAIC

of our findings,” said Alfred Sandrock head of research and development at Biogen.

Latest news

More from news
Approximately 1 fully matching, plus 15 partially matching documents found.

Latest appointments

  • Biogen's Douglas Williams departs for biotech start-up Biogen's Douglas Williams departs for biotech start-up

    Williams will be replaced by chief medical officer Alfred Sandrock and chief scientific officer Spyros Artavanis-Tsakonas, who will be handed joint responsibility for Biogen Research and Development. ... We are fortunate to have Al Sandrock and Spyros

  • Biogen Idec names VP for value-based medicine Biogen Idec names VP for value-based medicine

    Through his years of hands-on clinical experience, he has gained a truly unique understanding of the needs of MS patients,” said Alfred Sandrock, chief medical officer of Biogen Idec.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...